1326.2000 12.90 (0.98%)
NSE Jun 19, 2025 12:03 PM
Volume: 594.7K
 

Karvy
US business declines, margins outperform: DRL's revenues increased by 7% YoY to Rs 37.9 bn (lower than our estimates of Rs 38.9 bn) primarily due to de-growth in US business on account of higher pricing pressure due to incremental competition in some of the key products.
Dr. Reddy's Laboratories Ltd. is trading above all available SMAs
More from Dr. Reddy's Laboratories Ltd.
Recommended